Experiences of the molecular diagnosis of fragile X syndrome in Ecuador

dc.contributor.authorPozo Palacios, Juan Carlos
dc.contributor.authorLlamos Paneque, Arianne
dc.contributor.authorRivas, Christian
dc.contributor.authorOnofre, Emily
dc.contributor.authorLopez Caceres, Andrea Del pilar
dc.contributor.authorVillareal, Jennifer
dc.date.accessioned2022-02-08T16:37:05Z
dc.date.available2022-02-08T16:37:05Z
dc.date.issued2021
dc.description.abstractFragile X syndrome (FXS) is the most common cause of hereditary intellectual disability and the second most common cause of intellectual disability of genetic etiology. This complex neurodevelopmental disorder is caused by an alteration in the CGG trinucleotide expansion in fragile X mental retardation gene 1 (FMR1) leading to gene silencing and the subsequent loss of its product: fragile X mental retardation protein 1 (FMRP). Molecular diagnosis is based on polymerase chain reaction (PCR) screening followed by Southern blotting (SB) or Triplet primer-PCR (TP-PCR) to determine the number of CGG repeats in the FMR1 gene. We performed, for the first time, screening in 247 Ecuadorian male individuals with clinical criteria to discard FXS. Analysis was carried out by the Genetics Service of the Hospital de Especialidades No. 1 de las Fuerzas Armadas (HE-1), Ecuador. The analysis was performed using endpoint PCR for CGG fragment expansion analysis of the FMR1 gene. Twenty-two affected males were identified as potentially carrying the full mutation in FMR1 and thus diagnosed with FXS that is 8.1% of the sample studied. The average age at diagnosis of the positive cases was 13 years of age, with most cases from the geographical area of Pichincha (63.63%). We confirmed the familial nature of the disease in four cases. The range of CGG variation in the population was 12–43 and followed a modal distribution of 27 repeats. Our results were similar to those reported in the literature; however, since it was not possible to differentiate between premutation and mutation cases, we can only establish a molecular screening approach to identify an expanded CGG repeat, which makes it necessary to generate national strategies to optimize molecular tests and establish proper protocols for the diagnosis, management, and follow-up of patients, families, and communities at risk of presenting FXS. Copyright © 2021 Pozo-Palacios, Llamos-Paneque, Rivas, Onofre, López-Cáceres and Villareal.
dc.identifier.doi10.3389/fpsyt.2021.716311
dc.identifier.issn1664-0640
dc.identifier.urihttps://www.scopus.com/record/display.uri?eid=2-s2.0-85121809131&origin=resultslist&sort=plf-f&src=s&st1=Experiences+of+the+Molecular+Diagnosis+of+Fragile+X+Syndrome+in+Ecuador&sid=9c81de9cf244c46ca8aa3c7d76c0e1d4&sot=b&sdt=b&sl=86&s=TITLE-ABS-KEY%28Experiences+of+the+Molecular+Diagnosis+of+Fragile+X+Syndrome+in+Ecuador%29&relpos=0&citeCnt=0&searchTerm=
dc.language.isoes_ES
dc.sourceFrontiers in Psychiatry
dc.subjectDynamic mutation diseases
dc.subjectFMR1
dc.subjectFragile X syndrome
dc.subjectIntellectual disabilities
dc.subjectRepetitions
dc.titleExperiences of the molecular diagnosis of fragile X syndrome in Ecuador
dc.typeARTÍCULO
dc.ucuenca.afiliacionPozo, J., Universidad de Cuenca, Facultad de Ciencias Médicas, Cuenca, Ecuador
dc.ucuenca.afiliacionLlamos, A., Universidad Internacional del Ecuador, Quito, Ecuador
dc.ucuenca.afiliacionRivas, C., Hospital de Especialidades Fuerzas Armadas, Quito, Ecuador
dc.ucuenca.afiliacionOnofre, E., Hospital de Especialidades Fuerzas Armadas, Quito, Ecuador
dc.ucuenca.afiliacionLopez, A., Fundación Sante Fe de Bogotá, Bogotá, Ecuador
dc.ucuenca.afiliacionVillareal, J., Investigador Independiente, Ecuador, Ecuador
dc.ucuenca.areaconocimientofrascatiamplio3. Ciencias Médicas y de la Salud
dc.ucuenca.areaconocimientofrascatidetallado3.1.2 Genética Humana
dc.ucuenca.areaconocimientofrascatiespecifico3.1 Medicina Básica
dc.ucuenca.areaconocimientounescoamplio09 - Salud y Bienestar
dc.ucuenca.areaconocimientounescodetallado0912 - Medicina
dc.ucuenca.areaconocimientounescoespecifico091 - Salud
dc.ucuenca.cuartilQ1
dc.ucuenca.factorimpacto1.363
dc.ucuenca.idautor0104201579
dc.ucuenca.idautor1756888671
dc.ucuenca.idautorSgrp-4974-03
dc.ucuenca.idautorSgrp-4974-04
dc.ucuenca.idautor1760124865
dc.ucuenca.idautorSgrp-4974-06
dc.ucuenca.indicebibliograficoSCOPUS
dc.ucuenca.numerocitaciones0
dc.ucuenca.urifuentehttps://www.frontiersin.org/articles/10.3389/fpsyt.2021.716311/full
dc.ucuenca.versionVersión publicada
dc.ucuenca.volumenVolumen 12

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
documento.pdf
Size:
832.4 KB
Format:
Adobe Portable Document Format
Description:
document

Collections